A.M.A. serves as consultant to Novo Nordisk, Boehringer Ingelheim, Madrigal, GSK and Prosciento. Her institution has received research grants from Novo Nordisk, Pfizer, Target Pharma, Escopics, Oncoustics and Siemens. V.W.-S.W. served as a consultant or advisory board member for AbbVie, Boehringer Ingelheim, Echosens, Gilead Sciences, Intercept, Inventiva, Novo Nordisk, Pfizer, Sagimet Biosciences, TARGET PharmaSolutions and Visirna; and as a speaker for Abbott, AbbVie, Echosens, Gilead Sciences, Novo Nordisk and Unilab. He has received a research grant from Gilead Sciences and is a co-founder of Illuminatio Medical Technology. J.P.A. declares no competing interests.